Therapeutic Cancer Vaccines
Showing 1 - 25 of >10,000
Cancer, Tumors Trial in Liverpool, Bebington (ACIT-1)
Recruiting
- Cancer
- Neoplasms
- ACIT-1
-
Liverpool, Merseyside, United Kingdom
- +1 more
Feb 24, 2022
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Tumor Vaccines for Solid Tumors
Recruiting
- Glioma
- Solid Tumor
- tumor vaccine
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Oct 22, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women
Not yet recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, ChinaFujian Maternity and Child Health Hospital
Nov 16, 2023
Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)
Recruiting
- Advanced Pancreatic Cancer
- Personalized neoantigen tumor vaccine
-
Qionghai, Hainan, ChinaRuijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023
Recurrent or Metastatic Bladder Cancer Trial in Shanghai (Chimeric exosomal tumor vaccines)
Recruiting
- Recurrent or Metastatic Bladder Cancer
- Chimeric exosomal tumor vaccines
-
Shanghai, ChinaFudan University Pudong Medical Center
Sep 26, 2022
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide
Recruiting
- Pancreas Cancer
- +2 more
- Optimized neoantigen synthetic long peptide vaccine
- Poly-ICLC
-
Saint Louis, MissouriWashington University School of Medicine
Jan 23, 2023
Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)
Active, not recruiting
- Tuberculosis
- BCG Vaccine USP
- Isoniazid
-
Seattle, WashingtonFred Hutchinson Cancer Center
Dec 9, 2022
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Anti-cancer Immune Checkpoint Inhibition TowardsBetter
Not yet recruiting
- Cancer
- (no location specified)
Aug 1, 2023
Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)
Not yet recruiting
- Non-muscular Invasive Bladder Cancer
- BCG for therapeutic use
-
Changsha, ChinaHunan Cancer Hospital
Oct 20, 2023
Children Followed up With Cancer Diagnosis Trial in Ankara (Technology-based cognitive and artistic therapeutic activities)
Active, not recruiting
- Children Followed up With Cancer Diagnosis
- Technology-based cognitive and artistic therapeutic activities
-
Ankara, TurkeyGazi University
Mar 28, 2023
SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- Electronic Health Record Review
-
Duarte, California
- +10 more
Jan 12, 2023
Head Neck Cancer Trial (PET-MRI)
Not yet recruiting
- Head and Neck Cancer
- PET-MRI
- (no location specified)
Sep 4, 2023
Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous
Active, not recruiting
- Malignant Neoplasms of Brain
- tetanus toxoid
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy
Completed
- Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
- therapeutic mammoplasty
- (no location specified)
Jun 16, 2023
Cancer, Prostate Cancer, Colorectal Cancer Trial in Reykjavik (A digital solution for patients with Cancer, Standard of care for
Recruiting
- Cancer
- +3 more
- A digital solution for patients with Cancer
- Standard of care for patients with Cancer
-
Reykjavik, Iceland
- +1 more
Apr 9, 2023
Oncology Patients to Novel Coronavirus Vaccines (IROC)
Recruiting
- Cancer
- COVID-19 Vaccination
-
Carmel, Indiana
- +1 more
Aug 2, 2022
Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)
Not yet recruiting
- Metastatic Breast Cancer
- Unresectable Breast Cancer
- DiviTum® TKa assay
- CDK4/6 + Endocrine therapy
-
Saint Louis, MissouriWashington University School of Medicine
Jul 27, 2023
And Immuno-meDIated Adverse Events in Anti-cancer
Not yet recruiting
- Cancer
- (no location specified)
Jun 26, 2023
Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer
Not yet recruiting
- Locally Advanced Alveolar Soft Part Sarcoma
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 10, 2023
Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)
Active, not recruiting
- Multiple Myeloma
- CT-011
- Dendritic Cell Fusion Vaccine
-
Boston, Massachusetts
- +2 more
Sep 5, 2022